Literature DB >> 2476133

Immune responses to Borrelia burgdorferi in patients with reactive arthritis.

C M Weyand1, J J Goronzy.   

Abstract

In reactive arthritis (ReA), including Reiter's syndrome, a close relationship between chronic enteric and genitourinary infections and the clinical features of enthesitis has been described. In contrast, in Lyme arthritis, a distinct clinical entity, chronic infection with the tick-transmitted spirochete Borrelia burgdorferi has been associated with the disease. In a prospective study, 51 patients with ReA were tested for evidence of chlamydial and spirochetal infection. The presence of Chlamydia was determined by culture in 8 patients, and 7 additional patients had markedly elevated antibody titers. In 9 patients, antibodies specific to B burgdorferi were found. Purified peripheral blood T lymphocytes of all 9 patients proliferated specifically to stimulation with macrophages pre-pulsed with B burgdorferi antigens. Compared with other protein antigens, higher numbers of antigen-pulsed macrophages were necessary to activate B burgdorferi-specific T cells. Although antibody titers decreased in response to antibiotic treatment in 8 of 9 patients, second-line therapy with sulfasalazine or methotrexate was required to obtain clinical remission. These data suggest that chronic infection with B burgdorferi can cause ReA. In predisposed individuals, the arthritogenic immune response might be triggered by persisting infectious agents independent of their antigenic specificities.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476133     DOI: 10.1002/anr.1780320902

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  18 in total

Review 1.  Bacteria-Triggered reactive arthritis: implications for antibacterial treatment.

Authors:  A Toivanen
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 3.  Rheumatology.

Authors:  R A Asherson; R Cervera; D P D'Cruz; G R Hughes
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

4.  Lyme borreliosis: host responses to Borrelia burgdorferi.

Authors:  A Szczepanski; J L Benach
Journal:  Microbiol Rev       Date:  1991-03

5.  Clinically silent infections in patients with oligoarthritis: results of a prospective study.

Authors:  C M Weyand; J J Goronzy
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

6.  Autoimmune Arthritides, Rheumatoid Arthritis, Psoriatic Arthritis, or Peripheral Spondyloarthritis Following Lyme Disease.

Authors:  Sheila L Arvikar; Jameson T Crowley; Katherine B Sulka; Allen C Steere
Journal:  Arthritis Rheumatol       Date:  2017-01       Impact factor: 10.995

7.  Long-term results in patients with Lyme arthritis following treatment with ceftriaxone.

Authors:  H Valesová; J Mailer; J Havlík; D Hulínská; J Hercogová
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

8.  Does chlamydia trachomatis influence manifestations of Lyme Arthritis?

Authors:  O Lesnyak; L Sokolova; T Starikova; M Fadeeva; Y Beikin
Journal:  Clin Rheumatol       Date:  1996-07       Impact factor: 2.980

Review 9.  Treatment of Lyme arthritis.

Authors:  M A Cimmino; G L Moggiana; M Parisi; S Accardo
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

10.  Detection of anti-Borrelia burgdorferi antibody responses with the borreliacidal antibody test, indirect fluorescent-antibody assay performed by flow cytometry, and western immunoblotting.

Authors:  J R Creson; L C Lim; N J Glowacki; S M Callister; R F Schell
Journal:  Clin Diagn Lab Immunol       Date:  1996-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.